Home page > About us > Our Management
as.png am.png am.png

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Our Management

Ken McBean
President & Chief Executive Officer

Ken McBean has served as President since joining the company in September 2011. In March 2014, the Board of Directors of Chiesi S.p.A. appointed Mr. McBean to Chiesi’s Group Executive Committee and to the Board of Directors of Chiesi USA, Inc. In May 2014, Mr. McBean was also appointed Chief Executive Officer of Chiesi USA, Inc.

Jon Zwinski
Sr. Vice President - Business Unit Head, Cardiovascular

Jon Zwinski has served as Senior Vice President, Cardiovascular Business Unit Head since October 2019. Mr. Zwinski joined the company as Vice President, Sales in July 2012. Previously Mr. Zwinski served as Vice President of Sales at EKR Therapeutics. Since starting his career at Organon Pharmaceuticals in 1994, Mr. Zwinski has worked in many sales and national account roles beginning at the field level and progressing through field leadership to senior-level leadership roles.


Mr. Zwinski has broad experience across many therapeutic areas including anesthesia, women’s health, emergency medicine, psychiatry, neurology, neonatology, urology and cystic fibrosis. Throughout his career, Mr. Zwinski has led successful contracting and pull-through strategies with customers at the Managed Care, Trade, GPO, Hospital IDN, Hospital, and Specialty Pharmacy levels.

Alan T. Roberts
Senior Vice President, Scientific Affairs

Alan T. Roberts has served as Senior Vice President, Scientific Affairs/Compliance Officer since November 2015. Mr. Roberts joined the company as Vice President, Scientific Affairs in 2009. Prior to joining the company, Mr. Roberts founded Tybeam Pharma Consulting, LLC and served as its President. Previously, Mr. Roberts served as Senior Vice President and Chief Scientific Officer for Auriga Laboratories, Inc. Mr. Roberts also held various leadership positions at First Horizon Pharmaceutical Corporation and Mikart. In addition, Mr. Roberts held key management positions in regulatory and development at Solvay Pharmaceuticals, Inc.


Mr. Roberts holds a Bachelor of Science in Microbiology from Clemson University.

Amy Diebler
Vice President of Finance & Chief Financial Officer
Michael R. Gordon
Vice President, Legal Affairs & General Counsel

Michael R. Gordon joined the company as Vice President, Legal Affairs and General Counsel in 2014. Prior to joining the company, Mr. Gordon practiced law for almost twenty years. He began his career as an Assistant District Attorney in New York City in the Manhattan District Attorney’s Office under the Honorable Robert M. Morgenthau. Mr. Gordon also served as an associate and partner at the Raleigh, North Carolina law firm of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, LLP. Most recently, Mr. Gordon was a partner in the Research Triangle Park, North Carolina office of the international law firm of K&L Gates, LLP.


Mr. Gordon is admitted to the North Carolina and New York state bar. He earned a J.D. from Brooklyn Law School and a B.A. from Tulane University.

Carmen Dell'Anna, MD
Vice President, Medical Affairs

Carmen Dell’Anna, MD has served as Vice President, Medical Affairs since April 2019. Dr. Dell’Anna joined Chiesi in 2001 and has held key leadership roles in the clinical area, applying her broad global healthcare industry experience in both the U.S. and European Union. In these roles, she has guided medical strategy and execution, delivering scientific insights in support of the brands and product development.


Dr. Dell’Anna holds an MD degree from the University of Parma, Italy and is trained as a specialist in Clinical Endocrinology and Metabolic Diseases. Prior to joining Chiesi, Dr. Dell’Anna was in medical practice as an adult Endocrinologist for 7 years.